Krystal Biotech underperformed the market so far this year as of August 4, 2025.
1 report, 1 independent
Updated Aug 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Krystal Biotech underperformed the market so far this year as of August 4, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Krystal Biotech, Inc.
biotechnology company
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksKrystal Biotech, Inc. (KRYS) Tops Q2 Earnings and Revenue Estimates Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $1.29 per share, beating the Zacks Consensus Estimate of $1.08 per